234 related articles for article (PubMed ID: 15291359)
21. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
[TBL] [Abstract][Full Text] [Related]
22. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
[TBL] [Abstract][Full Text] [Related]
23. Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells.
Giannì M; Koken MH; Chelbi-Alix MK; Benoit G; Lanotte M; Chen Z; de Thé H
Blood; 1998 Jun; 91(11):4300-10. PubMed ID: 9596679
[TBL] [Abstract][Full Text] [Related]
24. The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages.
Alemany M; Levin J
Leuk Lymphoma; 2000 Jun; 38(1-2):153-63. PubMed ID: 10811458
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide: acute promyelocytic leukemia and beyond.
Bachleitner-Hofmann T; Kees M; Gisslinger H
Leuk Lymphoma; 2002 Aug; 43(8):1535-40. PubMed ID: 12400595
[TBL] [Abstract][Full Text] [Related]
26. In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies.
Giannì M; de Thé H
Leukemia; 1999 May; 13(5):739-49. PubMed ID: 10374879
[TBL] [Abstract][Full Text] [Related]
27. [Effects of protein tyrosine kinase, protein tyrosine phosphatase and protein kinase C on the apoptosis of arsenic trioxide treated NB4 cells and human cortex neurons].
Zhou J; Meng R; Sui XH; Lu M; Wang DS; Yang BF
Zhonghua Xue Ye Xue Za Zhi; 2004 Oct; 25(10):600-4. PubMed ID: 15634593
[TBL] [Abstract][Full Text] [Related]
28. [The mechanisms of arsenic trioxide-induced apoptosis in hematopoietic malignant cells].
Cai X; Chen G; Jia P
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):452-5. PubMed ID: 11715442
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.
Rojewski MT; Körper S; Schrezenmeier H
Leuk Lymphoma; 2004 Dec; 45(12):2387-401. PubMed ID: 15621751
[TBL] [Abstract][Full Text] [Related]
30. Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation.
Wang QQ; Zhou XY; Zhang YF; Bu N; Zhou J; Cao FL; Naranmandura H
Oncotarget; 2015 Sep; 6(28):25646-59. PubMed ID: 26213848
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells.
Takeshita A; Shinjo K; Naito K; Matsui H; Sahara N; Shigeno K; Horii T; Shirai N; Maekawa M; Ohnishi K; Naoe T; Ohno R
Leukemia; 2005 Aug; 19(8):1306-11. PubMed ID: 15920495
[TBL] [Abstract][Full Text] [Related]
32. [In vitro study on arsenic trioxide-inducing apoptosis in primary acute promyelocytic leukemie cells].
Tang W; Chen G; Shen Z; Chen L; Shi X; Jia P; Shi G; Ni J; Chen S; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 1997 Dec; 18(12):623-6. PubMed ID: 15625759
[TBL] [Abstract][Full Text] [Related]
33. In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide (As2O3) induces the solitary expression of CD66c (NCA-50/90), a member of the CEA family.
Di Noto R; Boccuni P; Costantini S; Dello Russo A; Lo Pardo C; Copia C; Annunziata M; Cimino R; Ferrara F; Del Vecchio L
Tissue Antigens; 1999 Dec; 54(6):597-602. PubMed ID: 10674975
[TBL] [Abstract][Full Text] [Related]
34. [Experimental study of low dose arsenic trioxide in treatment of patients with acute promyelocytic leukemia].
Jia PM; Zhu Q; Yu Y; Chen GQ; Chen SJ; Chen Z; Wang ZY; Tong JH
Ai Zheng; 2002 Apr; 21(4):337-40. PubMed ID: 12452006
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
[TBL] [Abstract][Full Text] [Related]
36. Arsenic trioxide induces apoptosis via the mitochondrial pathway by upregulating the expression of Bax and Bim in human B cells.
Baysan A; Yel L; Gollapudi S; Su H; Gupta S
Int J Oncol; 2007 Feb; 30(2):313-8. PubMed ID: 17203211
[TBL] [Abstract][Full Text] [Related]
37. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1.
Qian W; Liu J; Jin J; Ni W; Xu W
Leuk Res; 2007 Mar; 31(3):329-39. PubMed ID: 16882451
[TBL] [Abstract][Full Text] [Related]
38. Catalase activity and arsenic sensitivity in acute leukemia.
Coe E; Schimmer AD
Leuk Lymphoma; 2008 Oct; 49(10):1976-81. PubMed ID: 18949620
[TBL] [Abstract][Full Text] [Related]
39. [Double effects of arsenic trioxide (As2O3) on acute promyelocytic leukemic cell line].
Tang W; Chen G; Shi G
Zhonghua Yi Xue Za Zhi; 1997 Jul; 77(7):509-12. PubMed ID: 9772451
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
